Soluble klotho and mortality: The Ludwigshafen Risk and Cardiovascular Health Study

V.M. Brandenburg; M.E. Kleber; M.G. Vervloet; T.E. Larsson; A. Tomaschitz; S. Pilz; T. Stojakovic; G. Delgado; T.B. Grammer; N. Marx; W. Maerz; H. Scharnagl

doi:https://doi.org/10.1016/j.atherosclerosis.2015.08.017

Soluble klotho and mortality: The Ludwigshafen Risk and Cardiovascular Health Study

V.M. Brandenburg, M.E. Kleber, M.G. Vervloet, T.E. Larsson, A. Tomaschitz, S. Pilz, T. Stojakovic, G. Delgado, T.B. Grammer, N. Marx, W. Maerz, H. Scharnagl

Research output: Contribution to journal › Article › Academic › peer-review

34 Citations (Scopus)

Original language	English
Pages (from-to)	483-489
Journal	Atherosclerosis
Volume	242
Issue number	2
DOIs	https://doi.org/10.1016/j.atherosclerosis.2015.08.017
Publication status	Published - 2015

Access to Document

https://doi.org/10.1016/j.atherosclerosis.2015.08.017

Cite this

@article{e969a1f52f2742cb9b41f26c0f7a2d69,

title = "Soluble klotho and mortality: The Ludwigshafen Risk and Cardiovascular Health Study",

author = "V.M. Brandenburg and M.E. Kleber and M.G. Vervloet and T.E. Larsson and A. Tomaschitz and S. Pilz and T. Stojakovic and G. Delgado and T.B. Grammer and N. Marx and W. Maerz and H. Scharnagl",

year = "2015",

doi = "https://doi.org/10.1016/j.atherosclerosis.2015.08.017",

language = "English",

volume = "242",

pages = "483--489",

journal = "Atherosclerosis",

issn = "0021-9150",

publisher = "Elsevier Ireland Ltd",

number = "2",

}

TY - JOUR

T1 - Soluble klotho and mortality: The Ludwigshafen Risk and Cardiovascular Health Study

AU - Brandenburg, V.M.

AU - Kleber, M.E.

AU - Vervloet, M.G.

AU - Larsson, T.E.

AU - Tomaschitz, A.

AU - Pilz, S.

AU - Stojakovic, T.

AU - Delgado, G.

AU - Grammer, T.B.

AU - Marx, N.

AU - Maerz, W.

AU - Scharnagl, H.

PY - 2015

Y1 - 2015

U2 - https://doi.org/10.1016/j.atherosclerosis.2015.08.017

DO - https://doi.org/10.1016/j.atherosclerosis.2015.08.017

M3 - Article

C2 - 26298739

SN - 0021-9150

VL - 242

SP - 483

EP - 489

JO - Atherosclerosis

JF - Atherosclerosis

IS - 2

ER -